Carisma Therapeutics appoints interim VP of Finance, principal accounting officer

Carisma Therapeutics Inc.

Natalie McAndrew appointed interim VP of Finance effective Jan 1, 2025.
She will serve as principal financial officer and principal accounting officer.
Ms. McAndrew is a Senior Director at Danforth Advisors, providing finance and accounting services under a master services agreement.
Her background includes roles at Apertura Gene Therapy, Baudax Bio, Tmunity Therapeutics, Spark Therapeutics.
The services agreement with Danforth can be terminated by either party with 30 days cause or 60 days without cause.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.